Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

BT 7480

Next Previous
Drug Profile

BT 7480

Alternative Names: BT-7480

Latest Information Update: 09 Jul 2026

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Bicycle Therapeutics
  • Developer Bicycle Therapeutics; Cancer Research UK
  • Class Antineoplastics; Bicyclic peptide drug conjugates; Bicyclic peptides; Drug conjugates; Immunotherapies; Peptides
  • Mechanism of Action CD137 antigen agonists; Cytotoxic T lymphocyte stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes

Highest Development Phases

  • Phase I/II Solid tumours

Most Recent Events

  • 02 Jul 2026 Bicycle Therapeutics plans a phase II trial for Solid tumours (Late-stage disease, Metastatic disease) (IV) in August 2026 (NCT07681674)
  • 09 Apr 2026 BT 7480 is available for licensing as of 09 Apr 2026. https://www.bicycletherapeutics.com/pipeline/pipeline/
  • 09 Apr 2026 Bicycle Therapeutics intends to discontinue further development of BT 7480 after the first half of 2026

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top